These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2550580)

  • 1. Epstein-Barr virus replication in interferon-treated cells.
    Sharp NA; Arrand JR; Clemens MJ
    J Gen Virol; 1989 Sep; 70 ( Pt 9)():2521-6. PubMed ID: 2550580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids activate Epstein Barr virus lytic replication through the upregulation of immediate early BZLF1 gene expression.
    Yang EV; Webster Marketon JI; Chen M; Lo KW; Kim SJ; Glaser R
    Brain Behav Immun; 2010 Oct; 24(7):1089-96. PubMed ID: 20466055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of virus enzymes by phorbol esters and n-butyrate in Epstein-Barr virus genome-carrying Raji cells.
    Nutter LM; Grill SP; Li JS; Tan RS; Cheng YC
    Cancer Res; 1987 Aug; 47(16):4407-12. PubMed ID: 3038311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death.
    Inman GJ; Binné UK; Parker GA; Farrell PJ; Allday MJ
    J Virol; 2001 Mar; 75(5):2400-10. PubMed ID: 11160743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demethylation of the Epstein-barr virus origin of lytic replication and of the immediate early gene BZLF1 is DNA replication independent. Brief report.
    Falk KI; Ernberg I
    Arch Virol; 1999; 144(11):2219-27. PubMed ID: 10603176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of sublines of Epstein-Barr virus producing HR-1 cells and its implication in virus propagation in culture.
    Yao GQ; Tsai CH; Cheng YC
    Virus Genes; 1995 Feb; 9(3):247-55. PubMed ID: 7597803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of arabinofuranosylthymine on Epstein-Barr virus replication.
    Ooka T; Calender A
    Virology; 1980 Jul; 104(1):219-23. PubMed ID: 6249024
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines.
    Anisimová E; Saemundsen AK; Roubal J; Vonka V; Klein G
    J Gen Virol; 1982 Jan; 58 Pt 1():163-71. PubMed ID: 6292341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
    Le Roux F; Sergeant A; Corbo L
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of activation of the Epstein-Barr virus genome on expression of B cell differentiation antigens of Burkitt's lymphoma lines.
    Yokochi T; Inoue Y; Iwata H; Miyadai T; Kimura Y
    Microbiol Immunol; 1988; 32(9):957-64. PubMed ID: 2850450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus gene expression in interferon-treated cells. Implications for the regulation of protein synthesis and the antiviral state.
    Clarke PA; Sharp NA; Arrand JR; Clemens MJ
    Biochim Biophys Acta; 1990 Aug; 1050(1-3):167-73. PubMed ID: 2169891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of EBV DNA demethylation and of EBV-specific transcription in Daudi cells treated with TPA and n-butyrate.
    Collandre H; Guetard D; Montagnier L
    Intervirology; 1984; 22(4):201-10. PubMed ID: 6096292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate.
    Luka J; Kallin B; Klein G
    Virology; 1979 Apr; 94(1):228-31. PubMed ID: 220786
    [No Abstract]   [Full Text] [Related]  

  • 14. Short, discontinuous exposure to butyrate effectively sensitizes latently EBV-infected lymphoma cells to nucleoside analogue antiviral agents.
    Ghosh SK; Forman LW; Akinsheye I; Perrine SP; Faller DV
    Blood Cells Mol Dis; 2007; 38(1):57-65. PubMed ID: 17161633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon enhances the expression of epstein-Barr virus early antigen in Daudi cells.
    Tovey MG; Dron M; Gresser I
    J Gen Virol; 1982 May; 60(Pt 1):31-8. PubMed ID: 6178801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocaine potentiates the switch between latency and replication of Epstein-Barr virus in Raji cells.
    Di Francesco P; Lisi A; Rieti S; Manni V; Grimaldi S; Garaci E
    Biochem Biophys Res Commun; 1999 Oct; 264(1):33-6. PubMed ID: 10527836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox control of Epstein-Barr virus replication by human thioredoxin/ATL-derived factor: differential regulation of lytic and latent infection.
    Sono H; Teshigawara K; Sasada T; Takagi Y; Nishiyama A; Ohkubo Y; Maeda Y; Tatsumi E; Kanamaru A; Yodoi J
    Antioxid Redox Signal; 1999; 1(2):155-65. PubMed ID: 11228744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
    Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
    Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Productive infection of Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell lines (GT38 and GT39) derived from gastric tissues.
    Takasaka N; Tajima M; Okinaga K; Satoh Y; Hoshikawa Y; Katsumoto T; Kurata T; Sairenji T
    Virology; 1998 Aug; 247(2):152-9. PubMed ID: 9705908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.
    Westphal EM; Mauser A; Swenson J; Davis MG; Talarico CL; Kenney SC
    Cancer Res; 1999 Apr; 59(7):1485-91. PubMed ID: 10197618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.